Full-Time

Medical Science Liaison

Msl

Confirmed live in the last 24 hours

Heron Therapeutics

Heron Therapeutics

201-500 employees

Compensation Overview

$170k - $195k/yr

+ Bonus + Equity

Senior, Expert

Boston, MA, USA + 2 more

More locations: Philadelphia, PA, USA | New York, NY, USA

Preferred lived-in city is New York City; secondary preferences are Boston or Philadelphia.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Requirements
  • Advanced scientific degree (PharmD, PhD, DNP, MD or DO) required, PharmD preferred.
  • No prior industry experience required for entry-level MSL role, but must have recent and relevant post-graduate training and/or clinical experience within therapeutic area of interest to Heron: Perioperative services and/or Acute Pain.
  • 5+ years of recent MSL experience within therapeutic areas of interest to Heron required for Sr. MSL role; 10+ years of recent MSL experience within therapeutic area of interest to Heron required for Principal MSL role.
  • An established track record of effective and influential oral presentations and discussion to HCPs.
  • Strong scientific baseline knowledge in pharmacology, disease state, competitive landscape, clinical trial methods, implementation, and interpretation; possesses sound scientific and clinical judgment.
  • Strong compliance knowledge and adherence to corporate compliance in all aspects of job performance including those related to clinical trials, scientific presentations, and responses to unsolicited requests for information.
  • Outstanding verbal and written communication skills.
  • Strong customer-facing skills; listening skills; probing skills; and flexibility.
  • Excellent collaboration skills across multiple disciplines.
  • Must live within assigned region, within one hour of a major airport, and be able to travel overnight up to 70% as business requires.
  • Must have a valid driver’s license and in good standing.
Responsibilities
  • Develop, maintain, and manage collaborations with regional and national KOLs, HCPs, researchers/investigators, and other healthcare professionals.
  • Responsible for initiating, building, and fostering relationships with recognized clinicians, HCPs, clinician researchers, managed market providers and defined academic health care systems.
  • Maintain up-to-date knowledge of products, therapeutic alternative products, treatment guidelines, clinical treatment trends, clinical trials, and scientific activities within areas of interest to Heron, e.g. Acute Pain and postoperative analgesia, opioid stewardship, postoperative nausea and vomiting, or chemotherapy-induced nausea and vomiting.
  • Identify and develop meaningful and robust relationships with community and academic KOLs/HCPs in areas of interest to Heron. Provide meaningful scientific exchange to ensure that they understand the science and the clinical data associated with Heron products.
  • Extract and document insights gained through conduct of scientific exchange related to how the KOLs/HCPs view both Heron and competitor products, scientific data gaps, or other areas of interest defined by Heron.
  • Provide compliant support for academic and government researchers and healthcare providers interested in doing research with Heron products, including but not limited to the investigator-initiated trial (IIT) program.
  • Create awareness of Heron product attributes, therapeutic data, and appropriate use.
  • Develop and execute regional strategic KOL plans in response to overarching medical affairs objectives.
  • Disseminate relevant medical and scientific information and literature, within corporate guidelines, to support KOL/HCP education in response to unsolicited requests.
  • Provide real-time, field-based medical and scientific support to answer unsolicited requests about Heron products and related therapeutic areas.
  • Collaborate compliantly with commercial counterparts.
  • Participate in, and successfully complete, all assigned education / training on the Company’s SOPs, policies, product information, compliance, and regulatory education relevant to performing job function.
  • Responsible for appropriate documentation of all business activities, including timely reporting of interactions, insights, and expense reports.
  • Serve as a local medical and scientific resource for the medical community in therapeutic areas of interest to Heron Therapeutics.
  • Develop and demonstrate a thorough working knowledge of Heron, its products, current medical and scientific research, and publications in therapeutic areas of interest to Heron.
  • Work closely with the academic and community research organizations, patient care organizations, guideline committees, and medical personnel within various specialties and professional organizations, to ensure effective communication of the science and clinical data behind Heron products and disease areas of interest.
  • Respond in an appropriate and expeditious fashion to unsolicited requests from KOLs/HCPs.
  • Identify and prepare KOLs/HCPs in a compliant manner for scientific programs, advisory boards, and speaker programs, as appropriate.
  • Provide medical and scientific support for medical education initiatives (e.g., speaker training).
  • Deliver high quality educational presentations in a variety of settings (e.g., formulary committees, medical meetings, and allied healthcare professionals’ meetings).
  • Professionally represent Heron at assigned medical conferences, congresses, meetings, and programs.
  • Serve as a local medical and scientific resource for internal stakeholders.
  • Provide medical and scientific training support to internal colleagues upon request.
  • Participate in internal therapeutic advisory groups and project teams.
  • Provide local medical support for consultant and advisory meetings as needed.
  • Complete accurate and timely administrative reports, projects, and other required documentation.
  • Provide medical and scientific support to market access and payor customers upon request.
  • Provide support in the inception, creation, review, and approval process of medical and scientific resources as needed and upon request.
  • Serve as liaison between clinical investigators and internal stakeholders in support of research.
  • Maintain active and compliant involvement in raising awareness of all Heron sponsored trials.
  • Be responsible for first-line review of IITs originating from territory, and, in collaboration with medical leadership, facilitate the submission and review processes for IITs in a compliant manner.
  • Act as liaison between external clinical investigators and Heron internal colleagues to assure timely follow-up of all communications, from proposal to publication, where appropriate.
  • Provide support for corporate sponsored studies upon request.
  • Work closely with the Research & Clinical Development organizations to identify appropriate thought leaders/KOLs and sites for pre-clinical work and clinical trials as requested.
  • Work closely with HCPs and sites involved in clinical development work to assure a conduit for meaningful scientific exchange with Heron.
Desired Qualifications
  • PharmD preferred.

Company Size

201-500

Company Stage

IPO

Headquarters

San Diego, California

Founded

1983

Simplify Jobs

Simplify's Take

What believers are saying

  • ZYNRELEF's inclusion in NOPAIN Act could boost market adoption and sales.
  • Relocation to Cary, NC, facilitates strategic partnerships and skilled workforce access.
  • Mark Hensley's appointment as COO enhances operational efficiency and strategic execution.

What critics are saying

  • Increased competition in oncology drugs may impact Heron's market share.
  • Relocation to Cary, NC, may cause operational disruptions and talent retention issues.
  • Reliance on ZYNRELEF's success poses financial risk if sales expectations aren't met.

What makes Heron Therapeutics unique

  • Heron focuses on non-opioid pain management, aligning with the NOPAIN Act.
  • Relocation to Cary, NC, positions Heron in a growing biotech hub.
  • Heron's oncology care portfolio expansion targets innovative cancer treatment demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Company News

Stock Titan
Apr 28th, 2025
Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer

CARY, N.C., April 28, 2025 /PRNewswire/ - Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Mark Hensley as Chief Operating Officer.

PR Newswire
Feb 27th, 2025
Heron Therapeutics Announces Fourth Quarter And Full-Year 2024 Financial Results And Highlights Recent Corporate Updates

Achieved Q4 2024 GAAP Net Income of $3.6 million. Generated full-year 2024 Net Revenue of $144.2 million, up 14% year-over-year. Delivered full-year 2024 adjusted EBITDA of $8.6 million

PR Newswire
Feb 13th, 2025
Heron Therapeutics To Report Fourth Quarter And Full Year 2024 Financial Results On Thursday, February 27, 2025

CARY, N.C., Feb. 13, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Thursday, February 27, 2025, at 8:00 a.m. ET to report fourth quarter and full year 2024 financial results and discuss recent business highlights.The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron's website at www.herontx.com

North Carolina Biotechnology Center
Dec 30th, 2024
Heron to move headquarters from California to Cary, NC

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, will relocate its headquarters from San Diego, California, to Cary, North Carolina, effective Jan. 1, 2025, according to a recent company announcement.

PR Newswire
Dec 23rd, 2024
Heron Therapeutics Announces Corporate Headquarters Relocation To Cary, North Carolina

SAN DIEGO, Dec. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, announced today the relocation of the Company's headquarters from San Diego, California to Cary, North Carolina, effective January 1, 2025. A majority of Heron's Management Team and corporate employees work from the Cary office, which is near the Research Triangle Park ("RTP"), one of the most prominent high-tech research and development parks in the United States. The growing biotech community in Cary and its surrounding areas provides ample space for growth and expansion."We are excited to move our headquarters to Cary, North Carolina, which represents a significant milestone in Heron's journey," said Craig Collard, Chief Executive Officer of Heron. "This move will not only strengthen our ability to support our employees by centralizing our operations and resources, but also positions us in an excellent location from which we can continue making strategic partnerships as we growing our existing portfolio focused on improving the lives of patients in the acute and oncology care settings